Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
LogicMark, Inc. Announces Third Quarter 2025 Results
-
Great Elm Group Reports Fiscal 2026 First Quarter Financial Results
-
Locafy Reports Fiscal Fourth Quarter and Full Year 2025 Results
-
SUNation Energy to Participate in Bank of America 2025 Clean Tech Symposium
-
Firefly Aerospace Announces Third Quarter 2025 Financial Results
-
UTime Limited Announces 1-for-100 Reverse Stock Split
-
Li Bang International Announces Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency
-
TWFG Announces Third Quarter 2025 Results
-
Playboy Reports Third Quarter 2025 Financial Results
-
MaxCyte Announces Planned CFO Transition in 2026
-
Flutter Entertainment: Q3 2025 Update
-
Orezone Gold Reports Third Quarter 2025 Results
-
SoundThinking, Inc. Reports Third Quarter 2025 Financial Results
-
Oruka Therapeutics Reports Third Quarter 2025 Financial Results and Provides Corporate Update
-
Glass House Brands Reports Third Quarter 2025 Financial Results
-
Echo IQ Highlights Market Potential for EchoSolv AS Following Presentation of New Data for Severe Aortic Stenosis (AS) Presented at AHA Scientific Sessions 2025
-
eGain Announces First Quarter 2026 Financial Results
-
CNB Financial Corporation Announces Quarterly Dividend for Common Stock
-
Nusano Receives Innovation Impact Award from BioUtah
-
Gulf Island Reports Third Quarter 2025 Results
-
Wrap Reports $2M Gross Revenue in Q3 With Non-Lethal Response Launch
-
Aqua Metals Reports Third Quarter 2025 Results and Highlights Continued Progress Toward Commercialization of AquaRefining™ Technology
-
Dyadic Announces Third Quarter 2025 Financial Results and Highlights Strategic Progress
-
Michael Tschudy Joins Orrstown Bank as C&I Team Leader in York Region
-
SELLAS Life Sciences Reports Third Quarter 2025 Financial Results and Provides Corporate Update
-
Cue Biopharma Reports Third Quarter 2025 Financial Results and Recent Business Highlights
-
SKYX Reports Record Revenues of $24 Million in Third Quarter 2025 Compared to $23 Million for Second Quarter 2025 as it Continues to Grow its Market Penetration
-
Tenax Therapeutics Reports Third Quarter 2025 Financial Results and Provides Corporate Update
-
Kura Oncology to Participate in Upcoming Investor Conference
-
Espey Mfg. & Electronics Corp. reports first quarter results
-
Caribou Biosciences Reports Third Quarter 2025 Financial Results and Provides Business Update
-
Atea Pharmaceuticals Reports Third Quarter 2025 Financial Results and Provides Business Update
-
MYR Group Inc. to Attend Bernstein Insights Industrials Forum in December
-
dLocal Reports 2025 Third Quarter Financial Results
-
DeFi Development Corp. Reports Strong Third Quarter 2025 Earnings
-
BioRestorative Therapies Reports Third Quarter 2025 Financial Results and Provides Business Update
-
Bolt Biotherapeutics Reports Third Quarter 2025 Financial Results and Provides Business Update
-
MaxCyte Reports Third Quarter 2025 Financial Results and Reiterates Full Year 2025 Revenue Guidance
-
Urgently Announces Third Quarter 2025 Financial Results
-
GE HealthCare and RadNet’s DeepHealth Division Sign Letter of Intent to Advance Innovation and Adoption of AI-Powered Imaging Across Multiple Modalities and Remote Scanning
-
Immuneering Reports Third Quarter 2025 Financial Results and Provides Business and Clinical Updates
-
Taboola to Participate in Upcoming Investor Conferences
-
Digital Realty Announces Pricing of €600 million of Guaranteed Notes due 2033 and €800 million of Guaranteed Notes due 2037
-
authID Reports Financial and Operating Results for the Third Quarter 2025
-
Decent Holding Inc. Announces Closing of US$8 Million Registered Offering of Class A Ordinary Shares and Warrants
-
Korro Reports Third Quarter Financial Results, Provides Updates on KRRO-110 in Alpha-1 Antitrypsin Deficiency and Additional Pipeline Programs
-
Silvaco Reports Third Quarter 2025 Financial Results
-
Lyell Immunopharma Reports Business Highlights and Financial Results for the Third Quarter 2025
-
Fractyl Health Reports Third Quarter 2025 Results; Revita® Clinical Momentum Builds Toward 2026 Pivotal Readout and PMA Filing, Cash Runway Extended into Early 2027
-
Supernus to Participate in the 2025 Jefferies Global Healthcare Conference in London

